- All > Medicine Information and Evidence for Policy > Medicines Policy
- All > Medicine Access and Rational Use > Good Governance for Medicines
- All > Medicine Programme Coordination > Programme Coordination
- Keywords > access to medicines
- Keywords > accountability - pharmaceutical sector
- Keywords > availability, affordability, and quality of pharmaceutical products
- Keywords > corruption
- Keywords > key achievements
- Keywords > legal framework
- Keywords > MeTA - The Medicines Transparency Alliance
- Keywords > multi-stakeholder approach
- Keywords > pharmaceutical sector - good governance
- Keywords > transparency
(2016; 12 pages)
The Medicines Transparency Alliance (MeTA) began as a pilot in Ghana in 2009.
The programme aimed to contribute to good governance, transparency and accountability across the medicines supply chain, through the engagement of all stakeholders with an interest in access to medicines. MeTA Ghana is a registered body with a constitution. Its highest decision-making body is a governing council, which is made up of 20 representatives of government, civil society and private sector agencies. The governing council oversees the work of an advocacy subgroup, a technical subgroup, and an administrative subgroup made up of members from government, the private sector, civil society and cooperating partners. The council, which meets quarterly, oversees the implementation of the work plan and monitors the performance of the national secretariat.
Ghana is one of seven countries to adopt MeTA. The programme is also active in Jordan, Kyrgyzstan, Peru, the Philippines, Uganda and Zambia. It is currently funded by the UK Government through the Department for International Development (DFID).